US Stock MarketDetailed Quotes

INSM Insmed

Watchlist
  • 79.310
  • +0.640+0.81%
Close Feb 14 16:00 ET
  • 79.310
  • 0.0000.00%
Post 19:47 ET
14.19BMarket Cap-14.29P/E (TTM)

About Insmed Company

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Company Profile

SymbolINSM
Company NameInsmed
Listing DateJun 1, 2000
Founded1988
CEOMr. William H. Lewis
MarketNASDAQ
Employees912
Fiscal Year Ends12-31
Address700 US Highway 202/206
CityBridgewater
ProvinceNew Jersey
CountryUnited States of America
Zip Code08807-3365
Phone1-908-977-9900

Company Executives

  • Name
  • Position
  • Salary
  • William H. Lewis
  • Chairman of the Board, President and Chief Executive Officer
  • 10.41M
  • Sara Bonstein
  • Chief Financial Officer and Principal Accounting Officer
  • 4.56M
  • Drayton Wise
  • Chief Commercial Officer
  • 3.89M
  • Michael A. Smith
  • Chief Legal Officer, Senior Vice President, General Counsel and Secretary
  • --
  • Roger Adsett
  • Chief Operating Officer
  • 4.01M
  • Dr. Martina Flammer, M.B.A.
  • Chief Medical Officer
  • 4.22M
  • S. Nicole Schaeffer
  • Chief People Strategy Officer
  • --
  • Dr. Melvin Sharoky,M.D.
  • Independent Director
  • 312.50K
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 310.00K
  • David W.J. McGirr, M.B.A.
  • Independent Director
  • 320.00K
  • David R Brennan
  • Lead Independent Director
  • 345.00K
  • Dr. Clarissa Desjardins, PhD
  • Independent Director
  • 315.00K
  • Alfred F. Altomari
  • Independent Director
  • 320.00K
  • Leo Lee
  • Independent Director
  • 317.50K
  • Carol A. Schafer
  • Independent Director
  • 315.00K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More